Atossa Genetics - 12 Year Stock Price History | ATOS
Historical daily share price chart and data for Atossa Genetics since 2012 adjusted for splits and dividends. The latest closing stock price for Atossa Genetics as of May 01, 2024 is 1.53.
- The all-time high Atossa Genetics stock closing price was 2226.60 on March 19, 2013.
- The Atossa Genetics 52-week high stock price is 2.31, which is 51% above the current share price.
- The Atossa Genetics 52-week low stock price is 0.62, which is 59.5% below the current share price.
- The average Atossa Genetics stock price for the last 52 weeks is 0.98.
| Atossa Genetics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 1.2301 | 0.9350 | 2.1000 | 0.8000 | 1.5300 | 73.86% |
| 2023 | 0.8097 | 0.5862 | 1.3500 | 0.5862 | 0.8800 | 66.51% |
| 2022 | 1.0330 | 1.7400 | 1.7400 | 0.5020 | 0.5285 | -66.97% |
| 2021 | 3.0766 | 0.9500 | 8.6200 | 0.9207 | 1.6000 | 68.42% |
| 2020 | 2.1099 | 1.5900 | 4.3500 | 0.7850 | 0.9500 | -39.49% |
| 2019 | 2.0714 | 1.1600 | 7.0700 | 1.1100 | 1.5700 | 53.92% |
| 2018 | 3.2993 | 3.2400 | 9.9912 | 0.9169 | 1.0200 | -67.68% |
| 2017 | 8.4707 | 17.0400 | 21.6972 | 2.7000 | 3.1560 | -81.35% |
| 2016 | 44.0299 | 64.8000 | 118.8000 | 15.7200 | 16.9200 | -70.63% |
| 2015 | 204.7952 | 252.0000 | 365.4000 | 57.6000 | 57.6000 | -77.62% |
| 2014 | 291.3921 | 408.6000 | 575.9999 | 147.6180 | 257.4000 | -38.36% |
| 2013 | 892.7324 | 683.9999 | 2226.5998 | 315.0000 | 417.6000 | -40.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.192B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
| Edwards Lifesciences (EW) | United States | $50.799B | 33.06 |
| DexCom (DXCM) | United States | $50.060B | 75.83 |
| IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
| Alcon (ALC) | Switzerland | $38.723B | 28.56 |
| STERIS (STE) | Ireland | $20.261B | 23.98 |
| Waters (WAT) | United States | $18.737B | 26.89 |
| Hologic (HOLX) | United States | $17.905B | 19.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.452B | 15.38 |
| ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
| Teleflex (TFX) | United States | $9.964B | 15.65 |
| Penumbra (PEN) | United States | $7.957B | 98.22 |
| Masimo (MASI) | United States | $7.091B | 39.77 |
| Globus Medical (GMED) | United States | $6.827B | 21.64 |
| Glaukos (GKOS) | United States | $4.964B | 0.00 |
| TransMedics (TMDX) | United States | $3.847B | 367.50 |
| Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
| LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
| Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
| Inari Medical (NARI) | United States | $2.419B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
| RxSight (RXST) | United States | $2.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
| Veracyte (VCYT) | United States | $1.539B | 0.00 |
| OPKO Health (OPK) | United States | $0.885B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
| Artivion (AORT) | United States | $0.838B | 96.81 |
| Paragon 28 (FNA) | United States | $0.817B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
| IRadimed (IRMD) | United States | $0.532B | 30.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
| AxoGen (AXGN) | United States | $0.287B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
| Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.087B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |